Dutasteride Capsule
Product Images NDC 71205-039

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 71205-039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Dutasteride Structural Formula (Dutasteride Capsules 1)

Dutasteride Structural Formula (Dutasteride Capsules 1)
FDA Label Image

Figure 1. Aua-si Score* Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 2)

Figure 1. Aua-si Score* Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 2)
FDA Label Image

Figure 2. Percent Of Subjects Developing Acute Urinary Retention Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 3)

Figure 2. Percent Of Subjects Developing Acute Urinary Retention Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 3)
FDA Label Image

Figure 3. Percent Of Subjects Having Surgery For Benign Prostatic Hyperplasia Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 4)

Figure 3. Percent Of Subjects Having Surgery For Benign Prostatic Hyperplasia Over A 24-month Period (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 4)
FDA Label Image

Figure 4. Prostate Volume Percent Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 5)

Figure 4. Prostate Volume Percent Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 5)
FDA Label Image

Figure 5. Qmax Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 6)

Figure 5. Qmax Change From Baseline (randomized, Double-blind, Placebo-controlled Studies Pooled) (Dutasteride Capsules 6)
FDA Label Image

1968f777-figure-07 (Dutasteride Capsules 7)

1968f777-figure-07 (Dutasteride Capsules 7)
FDA Label Image

Figure 7. Qmax Change From Baseline (combat Study) (Dutasteride Capsules 8)

Figure 7. Qmax Change From Baseline (combat Study) (Dutasteride Capsules 8)
FDA Label Image

71205-039-90 (Dutasteride Capsules 9)

71205-039-90 (Dutasteride Capsules 9)
This is a medication bottle of Dutasteride capsules, each containing 0.5mg of the active ingredient. The bottle contains 90 capsules and has a lot number, batch number, and expiration date. The capsules are opaque, yellow, oblong, and imprinted with 'A 75'. The medicine is prescribed and is distributed only on RX. The manufacturer and distributor of the medicine are Amneal Pharmaceuticals Bridgewater in NJ, USA. The medicine bottle has a warning to read the manufacturer's warning information. The lot number is identified as SD003990. The medicine is stored in a temperature range of 20°C to 25°C and should be kept out of reach of children. The NDC number of the medicine is 71205-039-90. The bottle also shows that some of the capsules have been relabeled by Proficient Rx LP in Thousand Oaks, CA 91320.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.